Arteriocyte Medical Systems
Cleveland · Founded 2007
About Arteriocyte Medical Systems
Arteriocyte Medical Systems, Inc. is a leading medical device company dedicated to helping patients heal faster by developing innovative solutions to improve the outcomes of surgical procedures based on cell and tissue based therapies. The Company’s lead product is the Magellan® Autologous Platelet Separator. The Magellan® System provides surgeons the ability to fractionate peripheral blood and/or aspirated bone marrow from a patient, for that patient, at bedside in approximately 15 minutes using a fully automated closed loop separation process. The Magellan® device yields a 3-10cc injectable unit of platelet and stem cell enriched plasma for the surgeon’s use in his or her procedure.
Company Facts
- Founded: 2007
- Legal name: Arteriocyte Medical Systems Inc
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $10.8M
- Funding stage: M&A
- Last round: Debt Financing (Mar 2011)
- Website: arteriocyte.com
- Phone: 5084978951
Social Profiles
Canonical: https://fsome.com/organization/arteriocyte-medical-systems-8343931 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.